Anti-inflammatory agents as virostatic compounds
US9795590B2 · kind B2 · utility
5Cited by
0References
2Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 11, 2014 |
| Grant date | Oct 24, 2017 |
| Priority date | — |
| Expiry date | Apr 11, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of the general formula (I) and salts and physiologically functional derivatives thereof, for use in the treatment of medical conditions which are caused by an adeno virus, HHV (human herpesvirus), VZV (varicella zoster virus), HSV (herpes simplex virus), EBV (Epstein-Barr virus), vaccinia virus, or BK virus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.